Showing 145 to 156 of 158 results
Kennedy's Attorney's Anti-Vaccine Lobbying Raises Concerns During HHS Confirmation Hearing
Robert F. Kennedy Jr.'s attorney, Aaron Siri, lobbied the FDA to revoke the polio vaccine's approval, raising concerns during Kennedy's upcoming Senate confirmation hearing for the HHS Secretary position, where Senators McConnell and Schumer have voiced strong opposition.
Kennedy's Attorney's Anti-Vaccine Lobbying Raises Concerns During HHS Confirmation Hearing
Robert F. Kennedy Jr.'s attorney, Aaron Siri, lobbied the FDA to revoke the polio vaccine's approval, raising concerns during Kennedy's upcoming Senate confirmation hearing for the HHS Secretary position, where Senators McConnell and Schumer have voiced strong opposition.
Progress
56% Bias Score
FDA Mulls Ban on Cancer-Linked Food Dye Red 3
The FDA may soon ban Red 3, a synthetic food dye found in roughly 3,000 US food products, due to potential health risks highlighted by recent research linking it to hyperactivity and cancer in animals.
FDA Mulls Ban on Cancer-Linked Food Dye Red 3
The FDA may soon ban Red 3, a synthetic food dye found in roughly 3,000 US food products, due to potential health risks highlighted by recent research linking it to hyperactivity and cancer in animals.
Progress
48% Bias Score
USDA Mandates Bird Flu Testing for Raw Milk Amidst Ongoing Outbreak
The USDA announced it will mandate bird flu testing in raw milk due to an outbreak impacting 720 dairy herds across 15 states; this follows reports of H5N1 in pasteurized milk and ongoing raw milk promotion by Robert F. Kennedy Jr., despite known risks of bacterial contamination.
USDA Mandates Bird Flu Testing for Raw Milk Amidst Ongoing Outbreak
The USDA announced it will mandate bird flu testing in raw milk due to an outbreak impacting 720 dairy herds across 15 states; this follows reports of H5N1 in pasteurized milk and ongoing raw milk promotion by Robert F. Kennedy Jr., despite known risks of bacterial contamination.
Progress
56% Bias Score
Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Progress
40% Bias Score
Supreme Court to Hear Case on FDA's E-Cigarette Flavor Ban
The Supreme Court will hear a case on Monday challenging the FDA's rejection of flavored e-cigarette applications due to concerns about youth vaping; the companies argue the products help adults quit smoking.
Supreme Court to Hear Case on FDA's E-Cigarette Flavor Ban
The Supreme Court will hear a case on Monday challenging the FDA's rejection of flavored e-cigarette applications due to concerns about youth vaping; the companies argue the products help adults quit smoking.
Progress
36% Bias Score
Study Investigates Impact of Ultra-Processed Foods on Health
A study investigates the effects of ultra-processed foods on health, particularly weight gain and obesity, with the potential to inform future dietary guidelines.
Study Investigates Impact of Ultra-Processed Foods on Health
A study investigates the effects of ultra-processed foods on health, particularly weight gain and obesity, with the potential to inform future dietary guidelines.
Progress
32% Bias Score
FDA Proposes Nicotine Reduction in Cigarettes to Curb Addiction
The FDA submitted a proposed rule to lower nicotine in cigarettes to reduce addiction, potentially preventing 33 million from starting to smoke and helping 5 million quit within a year, based on earlier projections, though the final impact is unknown and subject to a lengthy regulatory process and p...
FDA Proposes Nicotine Reduction in Cigarettes to Curb Addiction
The FDA submitted a proposed rule to lower nicotine in cigarettes to reduce addiction, potentially preventing 33 million from starting to smoke and helping 5 million quit within a year, based on earlier projections, though the final impact is unknown and subject to a lengthy regulatory process and p...
Progress
40% Bias Score
FDA to Ban Red 3 Food Dye Amidst Health Concerns
The FDA is considering banning Red 3, a petroleum-based food dye found in approximately 3,000 products, due to concerns about its carcinogenicity and impact on children's behavior, following a petition and growing public pressure.
FDA to Ban Red 3 Food Dye Amidst Health Concerns
The FDA is considering banning Red 3, a petroleum-based food dye found in approximately 3,000 products, due to concerns about its carcinogenicity and impact on children's behavior, following a petition and growing public pressure.
Progress
56% Bias Score
FDA Recalls Multivitamin for Undeclared Drugs, Posing Health Risks
Armonia Natural Store LLC's OneMultivitaminic GAF-Plus Advance multivitamin has been recalled from 12 states due to undeclared dexamethasone, acetaminophen, and aspartame, posing serious health risks, particularly for those with PKU; 64 bottles are affected.
FDA Recalls Multivitamin for Undeclared Drugs, Posing Health Risks
Armonia Natural Store LLC's OneMultivitaminic GAF-Plus Advance multivitamin has been recalled from 12 states due to undeclared dexamethasone, acetaminophen, and aspartame, posing serious health risks, particularly for those with PKU; 64 bottles are affected.
Progress
40% Bias Score
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Progress
48% Bias Score
Trump's Public Health Picks Spark Controversy
President-elect Trump's picks for key public health roles spark controversy due to their backgrounds and potential conflicts of interest.
Trump's Public Health Picks Spark Controversy
President-elect Trump's picks for key public health roles spark controversy due to their backgrounds and potential conflicts of interest.
Progress
44% Bias Score
Lemsip's Effectiveness Questioned
An analysis of Lemsip, a popular British cold remedy, examines its effectiveness given concerns about the active ingredient phenylephrine.
Lemsip's Effectiveness Questioned
An analysis of Lemsip, a popular British cold remedy, examines its effectiveness given concerns about the active ingredient phenylephrine.
Progress
48% Bias Score
Showing 145 to 156 of 158 results